U.S. Competition Watchdog Decries Drug Deals
As Congress hears arguments on so-called authorized generics, a new report by the Federal Trade Commission reveals what the antitrust watchdog calls a worrisome rise in cozy deals between generic and...To view the full article, register now.
Already a subscriber? Click here to view full article